HOME >> MEDICINE >> NEWS
2005 global tuberculosis targets may be out of reach

An article in this week's issue of THE LANCET cautions that key targets for tuberculosis control-due to be reached by next year-are unlikely to be met unless renewed strategic action and financial support can be secured.

Tuberculosis remains a leading cause of death among adults in less-developed countries; incidence is rising in sub-Saharan Africa and countries in the former Soviet Union. A failure to provide treatment in accordance with the international standard of care can sometimes result in patients being unable to take treatment properly. This can lead to failure to cure the disease and to prevent subsequent relapse.

The tuberculosis control strategy recommended by WHO to tackle this problem is known by the "brand name" of DOTS (DirectObservations of Treatments). The whole DOTS package involves five separate aspects: improved political commitment and funding, diagnosis by a laboratory, regular supplies of essential drugs, strengthened programme supervision, and the use of standard drug treatment with at least the initial treatment being directly observed by a trained treatment supporter.

Mario C. Raviglione from WHO and colleagues discuss how, despite great progress, global targets (70% TB detection of which 85% should be treated) for tuberculosis case detection and cure might not be reached by 2005. The authors highlight the serious case-detection gap between estimated annual incident cases and those reported under the DOTS strategy.

Four key actions are outlined that could speed up progress towards reaching the targets: 1) equipping national tuberculosis programmes to have a stewardship role in engaging all health providers in implementing the DOTS strategy; 2) establishing the feasibility of national certification systems of DOTS coverage; 3) promoting community action to contribute to patient care and to voice demand for the DOTS strategy; and 4) increasing support to sub-Saharan Africa to counter HIV-1-fuelled tubercu
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-Mar-2004


Page: 1 2

Related medicine news :

1. Envisat enables first global check of regional methane emissions
2. New thrust needed to tackle health inequalities globally says UCL scientist
3. A global treatment for iron deficiency
4. 4 million more health workers required to improve global health
5. IU Medical School poised to host global HIV/AIDS conference
6. Tony Blair launches UKs new global AIDS strategy
7. Countries need greater support and less stringent conditions if global fund goals are to be met
8. Chronic diseases need global health attention
9. New global trials help to make FOSRENOL(R) the most extensively studied modern phosphate binder
10. ESC highlights need for screening and global risk management as statins move over the counter in UK
11. Urgent need for investment in human resources to respond to global health crises

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: global tuberculosis targets may out reach

(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... game with knights, nature, and peasants. , The ... to Eurogamer. The popularity of these games grew over ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs has prepared ... UniWigs during the Easter Holidays from today until April ... April Fools’ Day. , As the winter fades and ... Easter Festival, with religious origins to countries in Europe ... Christmas. The best wig provider, UniWigs, would like to ...
(Date:3/28/2015)... 2015 Centurion Service Group will be hosting ... April 2 at their Las Vegas warehouse, located at 4606 ... sale, which consists of equipment from hospitals and surgery centers ... a.m. PDT. , Buyers will find items of all ... are a one-stop-shop,” said Erik Tivin, CEO of Centurion. , ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Delaying ... not be necessary, according to research presented today at ... ) Specialty Day. , “Our study compared results for ... who underwent an additional glenohumeral joint capsule release procedure ... George Murrell MD, PhD, lead author from St. George ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Lately the ... media regarding recent changes and proposals around the NCAA. ... current and former collegiate student-athletes across a spectrum of ... reflect on common challenges. The special panel consists of ... in sports ranging from football, track and field, baseball, ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
(Date:3/27/2015)... , March 27, 2015 Biopharmaceutical ... The biopharmaceutical industry comes out on top as the ... a new report  from ndp│analytics. According to the  ... development (R&D) investment over the last decade, accounting for ... A Short Video on Medicare ...
(Date:3/27/2015)... , March 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... ® Complete Knee System. ... 20 th year since Zimmer first introduced the NexGen ... To date, more than five million implantations of the NexGen ... of the NexGen knee demonstrates the importance of design innovation ...
(Date:3/27/2015)... , March 27, 2015  Valeant Pharmaceuticals International, Inc. ... closing of its previously announced registered offering of common ... (the "Offering"). Pursuant to the Offering, the Company issued ... share, for aggregate gross proceeds of approximately $1.45 billion. ... U.S. Securities and Exchange Commission a final prospectus supplement ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3
Cached News: